Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
2.250
-0.130 (-5.46%)
At close: Oct 30, 2026, 4:00 PM EDT
2.288
+0.038 (1.69%)
After-hours: Oct 30, 2026, 7:44 PM EDT
Neuronetics Market Cap
Neuronetics has a market cap or net worth of $171.44 million as of October 30, 2026. It is the 21,520th most valuable company in the world and the 3,691st biggest in the United States. Its market cap has decreased by 10.61% in one year.
Market Cap
171.44M
Enterprise Value
238.77M
1-Year Change
-10.61%
Global Rank
Country Rank
#3,691 United States
Category
ChartMarket Cap Chart
Since June 28, 2018, Neuronetics's market cap has decreased from $451.30M to $171.44M, a decrease of -62.01%. That is a compound annual growth rate of -10.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 171.40M | 81.38% |
| Dec 31, 2025 | 94.50M | 93.25% |
| Dec 31, 2024 | 48.90M | -41.72% |
| Dec 29, 2023 | 83.90M | -55.13% |
| Dec 30, 2022 | 187.00M | 59.01% |
| Dec 31, 2021 | 117.60M | -44.21% |
| Dec 31, 2020 | 210.80M | 151.85% |
| Dec 31, 2019 | 83.70M | -75.40% |
| Dec 31, 2018 | 340.20M | -24.62% |
| Jun 28, 2018 | 451.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Standard BioTools | 243.40M |
| TriSalus Life Sciences | 242.91M |
| Electromed | 226.07M |
| Profound Medical | 213.67M |
| RxSight | 203.39M |
| Inogen | 193.73M |
| MaxCyte | 171.32M |
| Quanterix | 148.50M |